Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OmniComm Systems has announced the signing of a five year agreement for its Promasys investigator initiated trials (IITs) technology with Surrey Clinical Research Centre (Surrey CRC) at the University of Surrey, a UK based research center focused on the design and execution of Phase I and IIa trials in sleep, psychopharmacology, oncology, immunology and vaccines.
Subscribe to our email newsletter
After a thorough evaluation process of various commercially available technologies, Surrey CRC selected Promasys technology to manage its clinical research activities. Promasys ranked highest across all categories including ease of use, fast study build, data quality and integrity and volunteer recruitment.
Promasys’ versatility through its mobile technology and overall functionality, as well as its lower total cost-of-ownership, was also a significant factor in the decision.
Surrey CRC data management head Carol Stillwell noted the company looks forward to working with OmniComm Promasys.
"Having worked with several commercial technologies over the past couple of years, we were impressed by the ease of operation of the Promasys system, and with the backing of an established company such as OmniComm feel that Promasys will go from strength to strength," Stillwell.
Promasys will be used by Surrey CRC to support both in-house and external studies including investigator initiated trials (IITs), National Health Service (NHS) studies, and industry sponsored trials.